Status:
UNKNOWN
Faecal Microbiota Transplantation for Microscopic Colitis
Lead Sponsor:
Hvidovre University Hospital
Conditions:
Microscopic Colitis
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
A pilot study investigating if orally administrated faecal microbiota transplantation capsules have the potential to treat active microscopic colitis.
Eligibility Criteria
Inclusion
- Diagnosis of microscopic colitis
- Date of diagnosis/histological confirmation \< 12 months
- Active disease according to Hjortswang's criteria
Exclusion
- Diagnosed with ulcerative colitis or Crohn's disease
- Diagnosed with celiac disease
- Active gastrointestinal infection
- Previous bowel resection of bowel (except appendectomy)
- Previous cholecystectomy
- Treatment with systemic steroid within 4 weeks, including budesonide
- Antibiotics 3 months prior
- Severe immunodeficiency,
- Pregnancy, planned pregnancy and breastfeeding
- Treatment with constipants such as psyllium, loperamide, bile binders, opium drops or codeine up to 2 weeks before inclusion and during participation
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05998174
Start Date
September 1 2023
End Date
March 1 2025
Last Update
August 18 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.